|
⚲
|
| Keyboard |
| Hicklin Daniel J
✚
|
|
|---|---|
| CIK # | 0001260929 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001260929] | |
| 4 | [0001260929] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Werewolf Therapeutics Inc | |
| Hicklin Daniel J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 185,652 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 592,690 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 435,000 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 295,500 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2022-01-06 | Grant | 215,888 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2021-04-30 | Grant | 155,416 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2020-12-08 | Grant | 727,377 | $0.00 |